Argenx Se ARGX
NASDAQ ARGX
$818.95 -27.32 (-3.23%)
As of: Oct 16, 2026 · 3:59 PM EDT

Argenx Se (ARGX) Return on Sales [ROS] (2016 - 2026)

Updated

Argenx Se's Return on Sales [ROS] came in at 32.54% for Q2 2026, up 11.35 percentage points from 21.20% a year earlier and up 2.19 percentage points from the prior quarter.

Analysis

Argenx Se (ARGX) Return on Sales [ROS] (2016 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Argenx Se reported Return on Sales [ROS] of 30.63%, up 15.63 percentage points year-over-year; for FY2025, it was 25.38%, up 26.38 percentage points from FY2024.

  • Return on Sales [ROS] has increased in each of the last three years, with a five-year change of +1181.94 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Sales [ROS] was -0.99% in FY2024 (+34.70 pp), -35.69% in FY2023 (+144.07 pp), -179.76% in FY2022 (-109.63 pp) and -70.13% in FY2021 (+1086.42 pp).
  • The Q2 2026 figure represents the highest quarterly Return on Sales [ROS] since Q3 2017.
  • Year-over-year, Return on Sales [ROS] has increased for 16 consecutive quarters, with an average year-over-year change of +27.09 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Sales [ROS] over five years came in Q3 2022 (a gain of 24690.26 percentage points), and the weakest in Q3 2021 (a drop of 23525.11 percentage points).
  • Business Quant data shows ARGX's Return on Sales [ROS] at 30.35% (Q1 2026), 28.59% (Q4 2025) and 30.72% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 28.21%
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 37.86%
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn -3.52%
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 32.97%
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 20.57%
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn -133.21%
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 28.37%
10 Argenx Se 50.23 Bn 34.19 Bn 1.37 Bn 32.54%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 32.54%
Mar 31, 2026 30.35%
Dec 31, 2025 28.59%
Sep 30, 2025 30.72%
Jun 30, 2025 21.20%
Mar 31, 2025 17.59%
Dec 31, 2024 13.98%
Sep 30, 2024 2.48%
Jun 30, 2024 -9.52%
Mar 31, 2024 -23.46%
Dec 31, 2023 -37.03%
Sep 30, 2023 -24.49%
Jun 30, 2023 -37.91%
Mar 31, 2023 -47.58%
Dec 31, 2022 -65.99%
Sep 30, 2022 -158.87%
Jun 30, 2022 113.83%
Mar 31, 2022 -1,052.43%
Dec 31, 2021 -887.37%
Sep 30, 2021 829.05%
API Access

Argenx Se Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ARGX&period=max&api_key=YOUR_API_KEY